Cushing Syndrome Associated Myopathy: It Is Time for a Change
Open accessThe DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
Abstract
Cushing syndrome is the result of excessive levels of glucocorticoids. Endogenous Cushing syndrome is rare with an incidence of two to three cases per million per year. Clinically, the presentation consists of a characteristic phenotype including skin symptoms and metabolic manifestations. A frequent co-morbidity with high impact on quality of life is Cushing syndrome associated myopathy. It characteristically affects the proximal myopathy, impairing stair climbing and straightening up. The pathophysiology is complex and involves protein degradation via the forkhead box O3 (FOXO3) pathway, intramuscular fat accumulation, and inactivity-associated muscle atrophy. Surgical remission of Cushing syndrome is the most important step for recovery of muscle function. Restoration depends on age, co-morbidities and postoperative insulin-like growth factor concentrations. At average, functionality remains impaired during the long-term compared to age and sex matched control persons. Growth hormone therapy in individuals with impaired growth hormone secretion could be an option but has not been proved in a randomized trial.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Multiple types of skeletal muscle atrophy involve a common program of changes in gene expression
Lecker, S. H., Jagoe, R. T., Gilbert, A., Gomes, M., Baracos, V., Bailey, J., Price, S. R., Mitch, W. E., & Goldberg, A. L. (2004) · The FASEB Journal · doi:10.1096/fj.03-0610com · Cited by 1,539 · cited 1×
“The converse, protein degradation is regulated by components of the E3 ubiquitin proteosomal system (UPS), including muscle-ring finger protein-1 (MuRF1) and atrogin-1, both target cellular proteins to the proteasome for hydrolysis [54,55].”
BackgroundA unifying model for mTORC1-mediated regulation of mRNA translation
Thoreen, C. C., Chantranupong, L., Keys, H. R., Wang, T., Gray, N. S., & Sabatini, D. M. (2012) · Nature · doi:10.1038/nature11083 · Cited by 1,477
Protein degradation by the ubiquitin-proteasome pathway in normal and disease states
Lecker, S. H., Goldberg, A. L., & Mitch, W. E. (2006) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006010083 · Cited by 1,234
Glucocorticoids and cardiovascular disease
Walker, B. R. (2007) · European Journal of Endocrinology · doi:10.1530/eje-07-0455 · Cited by 529 · cited 1×
“The direct effects of prolonged hypercortisolism on the myocardium are poorly understood [40,49].”
BackgroundROSS, E. (1982) · The Lancet · doi:10.1016/s0140-6736(82)92749-0 · Cited by 390 · cited 1×
“Due to a strong predominance of women in pituitary and adrenal CS, the ratio of female to male patients is ≥3:1, with mortality rates higher in females than in males [7], and untreated with a mean life expectancy of 5 years [8].”
BackgroundLindsay, J. R., Nansel, T., Baid, S., Gumowski, J., & Nieman, L. K. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-1058 · Cited by 210 · cited 2×
“By comparison, CS patients have worse quality of life compared to patients with other pituitary diseases [14-16].”
BackgroundResultClayton, R. N., Jones, P. W., Reulen, R. C., Stewart, P. M., Hassan-Smith, Z. K., Ntali, G., Karavitaki, N., Dekkers, O. M., Pereira, A. M., Bolland, M., et al. (2016) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(16)30005-5 · Cited by 208
Andela, C. D., van Haalen, F. M., Ragnarsson, O., Papakokkinou, E., Johannsson, G., Santos, A., Webb, S. M., Biermasz, N. R., van der Wee, N. J. A., & Pereira, A. M. (2015) · European Journal of Endocrinology · doi:10.1530/eje-14-1101 · Cited by 164 · cited 2×
“By comparison, CS patients have worse quality of life compared to patients with other pituitary diseases [14-16].”
BackgroundResultStenholm, S., Mehta, N. K., Elo, I. T., Heliövaara, M., Koskinen, S., & Aromaa, A. (2014) · International Journal of Obesity · doi:10.1038/ijo.2013.214 · Cited by 111 · cited 1×
“Preservation of muscle function is a main determinant in health and disease [29], whereas impaired muscle function and sarcopenia are associated with frailty, impaired health related quality of life and increased mortality [30].”
BackgroundFifteen-year nationwide trends in systemic glucocorticoid drug use in Denmark
Laugesen, K., Jørgensen, J. O. L., Petersen, I., & Sørensen, H. T. (2019) · European Journal of Endocrinology · doi:10.1530/eje-19-0305 · Cited by 92
Recent Updates on the Diagnosis and Management of Cushing's Syndrome
Nieman, L. K. (2018) · Endocrinology and Metabolism · doi:10.3803/enm.2018.33.2.139 · Cited by 85 · cited 1×
“Patients also have thin arms and legs and increased intraabdominal, truncal, neck and facial fat accumulation and various other symptoms [2,3].”
BackgroundMortality in Cushing’s Disease
Clayton, R. N. (2010) · Neuroendocrinology · doi:10.1159/000315813 · Cited by 58 · cited 1×
“Late diagnosis of CS is associated with high morbidity and mortality [6].”
BackgroundGlucocorticoid receptor polymorphisms influence muscle strength in Cushing's syndrome
Müller, L. M., Kienitz, T., Deutschbein, T., Riester, A., Hahner, S., Burger-Stritt, S., Berr, C. M., Oßwald, A., Braun, L., Rubinstein, G., et al. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgz052 · Cited by 17 · cited 2×
“Peripheral blood leukocytes glucocorticoid receptor genotyping and muscle function was analysed in 205 patients with proven endogenous CS and 125 control [62].”
BackgroundSelf-citation
Cited by
Consensus on diagnosis and management of Cushing's disease: a guideline update
Fleseriu, M., Auchus, R., Bancos, I., Ben-Shlomo, A., Bertherat, J., Biermasz, N. R., Boguszewski, C. L., Bronstein, M. D., Buchfelder, M., Carmichael, J. D., et al. (2021) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(21)00235-7 · Cited by 953
Self-citationReincke, M., & Fleseriu, M. (2023) · JAMA · doi:10.1001/jama.2023.11305 · Cited by 256
Self-citationLong-term consequences of Cushing syndrome: a systematic literature review
Puglisi, S., Perini, A. M. E., Botto, C., Oliva, F., & Terzolo, M. (2024) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgad453 · Cited by 53
Vogel, F., Braun, L., Zopp, S., Nowak, E., Schreiner, J., Benz, I., Rubinstein, G., Künzel, H., Ritzel, K., Kroiss, M., et al. (2023) · European Journal of Endocrinology · doi:10.1093/ejendo/lvad041 · Cited by 28
Intelligent Systems for Muscle Tracking: A Review on Sensor‐Algorithm Synergy
Putcha, A., Nguyen, T., Smith, R., Choffin, R., & Bai, W. (2023) · Advanced Intelligent Systems · doi:10.1002/aisy.202200351 · Cited by 10
Metadata
- Authors
- Reincke, M.
- Venue
- Endocrinology and Metabolism
- Publisher
- Korean Endocrine Society
- Published
- 2021-06-30
- Volume
- 36
- Issue
- 3
- Pages
- 564-571
- ISSN
- 2093-596X (ISSN-L)
- 2093-5978
- OpenAlex
- W3171190030
- Cited by
- 28
- References
- 13
- FWCI
- 3.27
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.